A Cardiac-Specific Robotized Cellular Assay Identified Families of Human Ligands as Inducers of PGC-1α Expression and Mitochondrial Biogenesis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ruiz, Matthieu ^a   Courilleau, Delphine ^b   Jullian, Jean Christophe ^b,c   Fortin, Dominique ^a   Ventura Clapier, Renée ^a   Blondeau, Jean Paul ^b   Garnier, Anne ^a  

^a INSERM   (France)

^b IPSIT   (France)

^c UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIGAND; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STEROID HORMONE; VITAMIN B GROUP;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; BREATHING RATE; CELL ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HEART MITOCHONDRION; HEART MUSCLE CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PGC 1ALPHA GENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; ROBOTIZED CELLULAR ASSAY;

ANIMALS; CELLS, CULTURED; FATTY ACIDS; GONADAL STEROID HORMONES; HEAT-SHOCK PROTEINS; MITOCHONDRIAL TURNOVER; PROMOTER REGIONS, GENETIC; RATS; TRANSCRIPTION FACTORS; VITAMIN B COMPLEX;

RATTUS;

EID: 84867074297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046753     Document Type: Article

References (54)

1. Patten IS, Arany Z, (2011) PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab 2: 90-97.
2. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, et al. (2003) Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501.
3. Zoll J, Monassier L, Garnier A, N'Guessan B, Mettauer B, et al. (2006) ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101: 385-91.
4. Faerber G, Barreto-Perreia F, Schoepe M, Gilsbach R, Schrepper A, et al. (2011) Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor gamma coactivator levels and mitochondrial dysfunction. J Thorac Cardiovasc Surg 141: 492-500, 500.e1.
5. Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, et al. (2007) Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol 50: 1362-9.
6. Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, et al. (2009) Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II. Circ Heart Fail 2: 342-50.
7. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F, et al. (2010) Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 106: 1541-8.
8. Hu X, Xu X, Lu Z, Zhang P, Fassett J, et al. (2011) AMP activated protein kinase-alpha2 regulates expression of estrogen-related receptor-alpha, a metabolic transcription factor related to heart failure development. Hypertension 58: 696-703.
9. Wu Z, Boss O, (2007) Targeting PGC-1 alpha to control energy homeostasis. Expert Opin Ther Targets 11: 1329-38.
10. Ventura-Clapier R, Garnier A, Veksler V, Joubert F, (2011) Bioenergetics of the failing heart. Biochim Biophys Acta 1813: 1360-72.
11. Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E, et al. (2004) PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96: 189-94.
12. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, et al. (2011) Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem 286: 10605-17.
13. Civitarese AE, Smith SR, Ravussin E, (2007) Diet, energy metabolism and mitochondrial biogenesis. Curr Opin Clin Nutr Metab Care 10: 679-87.
14. Puigserver P, Wu Z, Park CW, Graves R, Wright M, et al. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-39.
15. Fernandez-Marcos PJ, Auwerx J, (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93: 884S-90.
16. Garnier A, Fortin D, Zoll J, N'Guessan B, Mettauer B, et al. (2005) Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J 19: 43-52.
17. Rimbaud S, Sanchez H, Garnier A, Fortin D, Bigard X, et al. (2009) Stimulus specific changes of energy metabolism in hypertrophied heart. J Mol Cell Cardiol 46: 952-9.
18. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-22.
19. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, et al. (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310: 314-7.
20. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, et al. (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3: e101.
21. Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, et al. (2008) The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol 295: H185-96.
22. Arany Z, He H, Lin J, Hoyer K, Handschin C, et al. (2005) Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1: 259-71.
23. Louch WE, Sheehan KA, Wolska BM, (2011) Methods in cardiomyocyte isolation, culture, and gene transfer. J Mol Cell Cardiol 51: 288-98.
24. Arany Z, Wagner BK, Ma Y, Chinsomboon J, Laznik D, et al. (2008) Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Proc Natl Acad Sci U S A 105: 4721-6.
25. Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, et al. (1999) Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 274: 29063-70.
26. Lau SL, Yuen ML, Kou CY, Au KW, Zhou J, et al. (2012) Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes. J Cell Biochem 113: 841-7.
27. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM, (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 100: 7111-6.
28. Irrcher I, Ljubicic V, Kirwan AF, Hood DA, (2008) AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLoS One 3: e3614.
29. Tannous BA, (2009) Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc 4: 582-91.
30. Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, et al. (2008) Sex-specific pathways in early cardiac response to pressure overload in mice. J Mol Med (Berl) 86: 1013-24.
31. Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ, (2006) Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact 163: 113-32.
32. Rowe GC, Jiang A, Arany Z, (2010) PGC-1 coactivators in cardiac development and disease. Circ Res 107: 825-38.
33. Scarpulla RC, (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88: 611-38.
34. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, et al. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3: 397-403.
35. Garcia-Roves P, Huss JM, Han DH, Hancock CR, Iglesias-Gutierrez E, et al. (2007) Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci U S A 104: 10709-13.
36. Bionaz M, Thering BJ, Loor JJ, (2012) Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-alpha activation. Br J Nutr 107: 179-91.
37. Haemmerle G, Moustafa T, Woelkart G, Buttner S, Schmidt A, et al. (2011) ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat Med 17: 1076-85.
38. Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, et al. (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76: 303-10.
39. Galvao TF, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, et al. (2012) High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 93: 24-32.
40. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119: 902-7.
41. Stanley WC, Dabkowski ER, Ribeiro RF Jr, O'Connell KA, (2012) Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 110: 764-76.
42. Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, et al. (2011) Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One 6: e26391.
43. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, et al. (1992) Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86: 1099-107.
44. Regitz-Zagrosek V, (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5: 425-38.
45. Hsieh YC, Yang S, Choudhry MA, Yu HP, Rue LW 3rd, et al (2005) PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage. Am J Physiol Heart Circ Physiol 289: H2665-72.
46. Hsieh YC, Choudhry MA, Yu HP, Shimizu T, Yang S, et al. (2006) Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J 20: 1109-17.
47. Rodriguez-Cuenca S, Monjo M, Gianotti M, Proenza AM, Roca P, (2007) Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17beta-estradiol, testosterone, and progesterone. Am J Physiol Endocrinol Metab 292: E340-6.
48. Forges T, Monnier-Barbarino P, Alberto JM, Gueant-Rodriguez RM, Daval JL, et al. (2007) Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 13: 225-38.
49. Austin RC, Lentz SR, Werstuck GH, (2004) Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11Suppl 1: S56-64.
50. Miche E, Herrmann G, Nowak M, Wirtz U, Tietz M, et al. (2006) Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure. Clin Res Cardiol 95Suppl 1: i117-24.
51. Maurer M, Burri S, de Marchi S, Hullin R, Martinelli M, et al. (2010) Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. Int J Cardiol 141: 32-8.
52. Leeds FS, Brass EP, (1994) Hepatic cobalamin deficiency induced by hydroxycobalamin[c-lactam] treatment in rats is associated with decreased mitochondrial mRNA contents and accumulation of polycistronic mitochondrial RNAs. J Biol Chem 269: 3947-51.
53. Jia H, Liu Z, Li X, Feng Z, Hao J, et al. (2010) Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model. Neurobiol Aging 31: 636-46.
54. Garcia MM, Gueant-Rodriguez RM, Pooya S, Brachet P, Alberto JM, et al. (2011) Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1alpha by PRMT1 and SIRT1. J Pathol 225: 324-335.